Kelly Creighton was Resigned as Vice President of Regulatory and Strategic Development at Clinipace

Date of management change: November 12, 2021 

What Happened?

Morrisville, -based Clinipace Resigned Kelly Creighton as Vice President of Regulatory and Strategic Development

 

About the Company

At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.

 

About the Person

Kelly Creighton is Vice President of Regulatory and Strategic Development at Clinipace. Previously, Kelly held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Wingfield James, Dehn Lynda, Cheng Lee, Siskel Edward, Shah Farah, Mendiratta Vipul, Docherty Christine, Gates KaLynn, McDermott Tricia, Mapp Richard, Sulzer Stefan

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.